Low-Dose Ketamine and Seizure Disorder Safety Guide

A seizure disorder does not automatically disqualify you from low-dose ketamine treatment, but it is one of the conditions prescribers screen for most closely before starting a protocol for depression or chronic pain. The reason is that ketamine's effect on seizure threshold is not settled in one direction: research has explored it as a potential anticonvulsant in specific hospital settings, while separate studies at low, subanesthetic doses have occasionally recorded abnormal brain electrical activity. This is educational information, not medical advice. If you have a history of seizures, that history needs to be reviewed by a licensed clinician before any ketamine protocol begins.

What the Evidence on Ketamine and Seizures Actually Shows

Ketamine works by blocking the N-methyl-D-aspartate (NMDA) receptor, a type of glutamate receptor involved in both mood regulation and the electrical signaling that drives seizures. That dual role is why the research points in two directions depending on the dose and the clinical setting.

At anesthetic-level doses, ketamine has been studied as an add-on treatment for refractory status epilepticus, a prolonged seizure that fails to respond to first-line medications, which has led some researchers to describe NMDA receptor blockade as potentially anticonvulsant in specific hospital settings. You can review published research on this topic through PubMed, the National Library of Medicine's index of peer-reviewed studies. At the low, subanesthetic doses used for depression and chronic pain, the picture is different: EEG studies have occasionally recorded epileptiform discharges, brief abnormal electrical bursts, in people without a clinical seizure resulting. That gap between a flagged EEG finding and an actual seizure is exactly what makes this an open question rather than a settled answer.

Only esketamine (Spravato), the FDA-approved nasal spray form of ketamine, carries official labeling for treatment-resistant depression. Low-dose ketamine prescribed for depression or chronic pain outside that approval is used off-label, meaning the dose, schedule, and screening criteria come from a prescriber's clinical judgment and published research rather than an FDA-reviewed protocol.

How Screening for Seizure Risk Typically Works

Before starting a low-dose ketamine protocol, most prescribers ask a structured set of questions about seizure history as part of broader intake screening, not a one-time checkbox. That typically includes your diagnosis and type of seizure disorder, how recently you've had a seizure, whether it's currently controlled on medication, and whether a neurologist is already involved in your care. If you're comparing ketamine against other options, the ketamine therapy vs tms guide walks through the full contraindications and screening checklist clinics use before starting treatment.

For some patients, a prescriber may request a recent EEG or a neurology consult before approving a protocol, particularly if seizure control has changed recently or if the seizure disorder is poorly documented. This is a case-by-case clinical decision, not a fixed rule, and it should be made jointly between you, your prescriber, and your neurologist if you have one.

Related Safety Factors Worth Reviewing

Seizure history is one factor among several that shape whether a low-dose ketamine protocol is appropriate and how it should be monitored over time. If you're building a full picture before a first appointment, it helps to also review can you drive after ketamine treatment guidance, since dissociation during a session carries its own short-term safety rules regardless of seizure status. For anyone considering ongoing maintenance dosing, the ketamine tolerance and long-term use what clinicians need to know guide covers how response and dosing needs can shift over months of treatment.

Because ketamine is processed by the liver, prescribers also track liver health over time; the ketamine and liver function tests monitoring lfts during therapy guide explains how that monitoring works. And since cognition is a separate concern from seizure risk, the cognitive effects of repeated low-dose ketamine neuropsychological assessment guide covers what repeated dosing studies have found so far.